Develops drugs for cancer and inflammatory diseases.
Aug 2026Revenue $702M/yrExpenses $412M/yr
Reached break-even Jul 2026
Figures by year
When did Nurix Therapeutics become profitable?
Its revenue passed its expenses in Jul 2026. In the 12 months to Aug 2026, revenue was $702M and expenses $412M.
| Fiscal year to | Revenue | Expenses | Operating profit |
|---|---|---|---|
| Nov 2025 | $84.0M | $370M | −$286M |
| Nov 2024 | $54.5M | $268M | −$213M |
| Nov 2023 | $77.0M | $232M | −$155M |
| Nov 2022 | $38.6M | $222M | −$184M |
| Nov 2021 | $29.8M | $148M | −$118M |
| Nov 2020 | $17.8M | $82.8M | −$65.0M |
| Nov 2019 | $31.1M | $53.4M | −$22.2M |
When the cash runs out, on the chart. A red line at the date the company’s cash would run out at its latest burn, so you can see whether it gets to break-even first. Part of a subscription.